Photographs of the Symposium

1. Dr. Keane chaired the opening and touched the Japanese tradition regarding lipids and the kidney.   2. Dr. Kasiske gave the keynote address of the kidney and lipids at the opening.   3. Dr. Hirashio presented gene abnormality of LCAT deficiency.   4. Dr. Hiromura presented autoantibody of LCAT and received the Poster Session Award.   5. Dr. Saito chaired the session of LPG with Dr. Atkins and reviewed topics of LPG.   6. Dr. Stratikos presented APOE mutations in LPG.   7. Dr. Ito presented FcRγ deficiency in animal LPG and received the Poster Session Award.   8. Dr. Mooyaart presented genetic association in diabetic nephropathy.   9. Dr. O’Toole presented the APOL1 associations with kidney disease.   10. Dr. Muso presented the effect of LDL apheresis in nephrotic syndrome.   11. Dr. Holdaas presented results of the ALLERT trial.   12. see more Dr. Fellström presented results of AURORA study.   13. Dr. Upadhyay Selumetinib chemical structure presented meta-analysis of statins in CKD.   14. Dr. Wanner chaired the session of lipid-lowering treatment in CKD with Dr. Shoji, presented results of the 4D study and summarized KDIGO guideline.   15. Participants in the final session.   References 1. Virchow R. A more precise account of fatty metamorphosis. In: Chance F, editor. Cellular pathology. 2nd ed. Birmingham: Gryphon Editions; 1860. p.

342–66. 2. Munk F. Die Nephrosen. Die Lipoidnephrose. Medsche Klin. 1916;12:1047–76. 3. Kimmelstiel P, Wilson C. Intercapillary lesions in the glomerulus of the kidney. Am J Pathol. 1936;12:83–98.PubMedCentralPubMed 4. Moorhead JF, Chan MK, El Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2:1309–11.PubMedCrossRef 5. Keane WF, Yukawa S, Mune M. Lipids and renal disease. Kidney Int Suppl. 1999;56(S71):S1–259.CrossRef 6. Strom EH, Sund S, Reier-Nilsen M, Dorje C, Leren TP. Lecithin: cholesterol acyltransferase (LCAT) deficiency:

renal lesions with early graft recurrence. Ultrastruct Pathol. 2011;35:139–45.PubMedCrossRef 7. Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, et al. Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol. 2013;24:1305–12.PubMedCrossRef Amisulpride 8. Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006;47:199–211.PubMedCrossRef 9. Ishigaki Y, Oikawa S, Suzuki T, Usui S, Magoori K, Kim DH, et al. Virus-mediated transduction of apolipoprotein E (ApoE)-Sendai develops lipoprotein glomerulopathy in ApoE-deficient mice. J Biol Chem. 2000;275:31269–73.PubMedCrossRef 10. Mooyaart AL, Valk EJ, Van Es LA, Bruijn JA, de Heer E, Freedman BI, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54(3):544–53.PubMedCentralPubMedCrossRef 11. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al.